Adamas Pharmaceuticals, Inc. EPS - Earnings per Share 2014-2021 | ADMS
Adamas Pharmaceuticals, Inc. eps - earnings per share from 2014 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Adamas Pharmaceuticals, Inc. Annual EPS |
| 2020 |
$-2.03 |
| 2019 |
$-3.80 |
| 2018 |
$-4.87 |
| 2017 |
$-3.97 |
| 2016 |
$-2.77 |
| 2015 |
$-2.86 |
| 2014 |
$0.53 |
| 2013 |
$2.99 |
| 2012 |
$1.17 |
| Adamas Pharmaceuticals, Inc. Quarterly EPS |
| 2021-09-30 |
$-0.43 |
| 2021-06-30 |
$-0.27 |
| 2021-03-31 |
$-0.36 |
| 2020-12-31 |
$-0.65 |
| 2020-09-30 |
$-0.42 |
| 2020-06-30 |
$-0.37 |
| 2020-03-31 |
$-0.59 |
| 2019-12-31 |
$-0.83 |
| 2019-09-30 |
$-0.99 |
| 2019-06-30 |
$-0.90 |
| 2019-03-31 |
$-1.08 |
| 2018-12-31 |
$-1.04 |
| 2018-09-30 |
$-1.22 |
| 2018-06-30 |
$-1.26 |
| 2018-03-31 |
$-1.35 |
| 2017-12-31 |
$-1.28 |
| 2017-09-30 |
$-1.04 |
| 2017-06-30 |
$-0.93 |
| 2017-03-31 |
$-0.72 |
| 2016-12-31 |
$-0.68 |
| 2016-09-30 |
$-0.66 |
| 2016-06-30 |
$-0.78 |
| 2016-03-31 |
$-0.65 |
| 2015-12-31 |
$-0.58 |
| 2015-09-30 |
$-0.81 |
| 2015-06-30 |
$-0.78 |
| 2015-03-31 |
$-0.69 |
| 2014-12-31 |
$0.89 |
| 2014-09-30 |
$-0.57 |
| 2014-06-30 |
$0.88 |
| 2014-03-31 |
$-0.67 |
| 2013-12-31 |
$2.00 |
| 2013-09-30 |
$-0.36 |
| 2013-06-30 |
$-0.35 |
| 2013-03-31 |
$1.70 |
